SNDL Stock News: Sundial Growers enters a bid for the acquisition of Zenabis
Premium|Take advantage of 60% OFF on your first month.
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
You have reached your limit of 5 free articles for this month.
BLACK FRIDAY SALE! 60% OFF!
Grab this special offer, it's 7 months for FREE deal! And access ALL our articles and analysis.
CLAIM OFFER- NASDAQ:SNDL posted a 0.48% loss over the past five trading sessions.
- Sundial is entering a bid for the acquisition of Zenabis Global.
- Sundial could be looking to open its warchest to grow through acquisitions.
NASDAQ:SNDL managed to reclaim the $0.30 price level at the end of last week but the stock still posted a loss for the previous five trading sessions. Sundial has struggled this year, posting a 49% loss in 2022 and remains in jeopardy of being delisted from the NASDAQ exchange after falling below the $1.00 price level. Rumors of a reverse split have not helped the stock, which finds itself out of favor with even the meme stock crowd. With a short interest of just 9.14%, it doesn’t seem like even a short squeeze will be able to push Sundial back over $1.00.
Stay up to speed with hot stocks' news!
Over the weekend, Sundial emerged as a potential candidate to acquire the Zenabis Group, which is a subsidiary of Quebec-based company Hexo (NASDAQ:HEXO). Sundial made an application to make a stalking horse bid, which is a bid to acquire the assets and resources of a bankrupt entity. Hexo recently sold a stake of its company to Canadian cannabis giant Tilray (NASDAQ:TLRY). The Zenabis assets would include a grow facility in New Brunswick which produces over 46,000 kilograms of dried cannabis per year.
Sundial stock forecast
Sundial could finally be making use of its warchest of cash to make more acquisitions within the industry. Earlier this year, Sundial closed on its acquisition of Canadian liquor distributor, Alcanna, which should reap benefits for Sundial as early as this next quarter. With no debt on its balance sheet, Sundial is in a fortunate position to be able to make acquisitions, and it looks like Zenabis is the company’s first target following the close of the Alcanna deal.
Like this article? Help us with some feedback by answering this survey:
- NASDAQ:SNDL posted a 0.48% loss over the past five trading sessions.
- Sundial is entering a bid for the acquisition of Zenabis Global.
- Sundial could be looking to open its warchest to grow through acquisitions.
NASDAQ:SNDL managed to reclaim the $0.30 price level at the end of last week but the stock still posted a loss for the previous five trading sessions. Sundial has struggled this year, posting a 49% loss in 2022 and remains in jeopardy of being delisted from the NASDAQ exchange after falling below the $1.00 price level. Rumors of a reverse split have not helped the stock, which finds itself out of favor with even the meme stock crowd. With a short interest of just 9.14%, it doesn’t seem like even a short squeeze will be able to push Sundial back over $1.00.
Stay up to speed with hot stocks' news!
Over the weekend, Sundial emerged as a potential candidate to acquire the Zenabis Group, which is a subsidiary of Quebec-based company Hexo (NASDAQ:HEXO). Sundial made an application to make a stalking horse bid, which is a bid to acquire the assets and resources of a bankrupt entity. Hexo recently sold a stake of its company to Canadian cannabis giant Tilray (NASDAQ:TLRY). The Zenabis assets would include a grow facility in New Brunswick which produces over 46,000 kilograms of dried cannabis per year.
Sundial stock forecast
Sundial could finally be making use of its warchest of cash to make more acquisitions within the industry. Earlier this year, Sundial closed on its acquisition of Canadian liquor distributor, Alcanna, which should reap benefits for Sundial as early as this next quarter. With no debt on its balance sheet, Sundial is in a fortunate position to be able to make acquisitions, and it looks like Zenabis is the company’s first target following the close of the Alcanna deal.
Like this article? Help us with some feedback by answering this survey:
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.